p53's believe it or not: Lessons on transcription-independent death

Journal of Clinical Immunology

Volumn 23, Issue 5, 2003, Pages 355-361

  Chipuk, Jerry E ^a   Green, Douglas R ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

Apoptosis; Mitochondria; Mutants; p53; Transcription independent

Indexed keywords

FAS ANTIGEN; MUTANT PROTEIN; PROTEIN P53;

APOPTOSIS; CELL CYCLE; CELL DEATH; CYTOPLASM; DNA DAMAGE; DNA REPAIR; GENETIC TRANSCRIPTION; GENOME; HUMAN; MITOSIS INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; TRANSACTIVATION; TRANSCRIPTION REGULATION;

ANIMALS; APOPTOSIS; CELL MEMBRANE; HUMANS; MITOCHONDRIA; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0041330430     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1025365432325     Document Type: Review

References (35)

1. Caelles C, Helmberg A, Karin M: p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature 370:220-223, 1994
2. Michalovitz D, Halevy O, Oren M: Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53. Cell 62:671-680, 1990
3. Vogelstein B, Kinzler KW: Tumour-suppressor genes. X-rays strike p53 again. Nature 370:174-175, 1994
4. Gottlieb E, Lindner S, Oren M: Relationship of sequence-specific transactivation and p53-regulated apoptosis in interleukin 3-dependent hematopoietic cells. Cell Growth Differ 7:301-310, 1996
5. Bissonnette N, Wasylyk B, Hunting DJ: The apoptotic and transcriptional transactivation activities of p53 can be dissociated. Biochem Cell Biol 75:351-358, 1997
6. Yan Y, Shay JW, Wright WE, Mumby MC: Inhibition of protein phosphatase activity induces p53-dependent apoptosis in the absence of p53 transactivation. J Biol Chem 272:15220-15226, 1997
7. Haupt Y, Rowan S, Shaulian E, Vousden KH, Oren M: Induction of apoptosis in HeLa cells by trans-activation-deficient p53. Genes Dev 9:2170-2183, 1995
8. Ishioka C, Englert C, Winge P, Yan YX, Engelstein M, Friend SH: Mutational analysis of the carboxy-terminal portion of p53 using both yeast and mammalian cell assays in vivo. Oncogene 10:1485-1492, 1995
9. Rowan S, Ludwig RL, Haupt Y, Bates S, Lu X, Oren M, Vousden KH: Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant. EMBO J 15:827-838, 1996
10. Gottlieb TM, Oren M: p53 and apoptosis. Semin Cancer Biol 8:359-368, 1998
11. Yonish-Rouach E, Deguin V, Zaitchouk T, Breugnot C, Mishal Z, Jenkins JR, May E: Transcriptional activation plays a role in the induction of apoptosis by transiently transfected wild-type p53. Oncogene 11:2197-2205, 1995
12. Wang XW, Vermeulen W. Coursen JD, Gibson M, Lupold SE, Forrester K, Xu G, Elmore L, Yeh H, Hoeijmakers JH, Harris CC: The XPB and XPD DNA helicases are components of the p53-mediated apoptosis pathway. Genes Dev 10:1219-1232, 1996
13. Chen X, Ko LJ, Jayaraman L, Prives C: p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes Dev 10:2438-2451, 1996
14. Sjalander A, Birgander R, Hallmans G, Cajander S, Lenner P, Athlin L, Beckman G, Beckman L: p53 polymorphisms and haplotypes in breast cancer. Carcinogenesis 17:1313-1316, 1996
15. Walker KK, Levine AJ: Identification of a novel p53 functional domain that is necessary for efficient growth suppression. Proc Natl Acad Sci USA 93:15335-15340, 1996
16. Sakamuro D, Sabbatini P, White E, Prendergast GC: The polyproline region of p53 is required to activate apoptosis but not growth arrest. Oncogene 15:887-898, 1997
17. Oltvai ZN, Milliman CL, Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609-619, 1993
18. Borner C: The Bcl-2 protein family: Sensors and checkpoints for life-or-death decisions. Mol Immunol 39:615-647, 2003
19. Venot C, Maratrat M, Dureuil C, Conseiller E, Bracco L, Debussche L: The requirement for the p53 proline-rich functional domain for mediation of apoptosis is correlated with specific PIG3 gene transactivation and with transcriptional repression. EMBO J 17:4668-4679, 1998
20. Bennett M, Macdonald K, Chan SW, Luzio JP, Simari R, Weissberg P: Cell surface trafficking of Fas: A rapid mechanism of p53-mediated apoptosis. Science 282:290-293, 1998
21. Reinke V, Lozano G: The p53 targets mdm2 and Fas are not required as mediators of apoptosis in vivo. Oncogene 15:1527-1534, 1997
22. Schuler M, Bossy-Wetzel E, Goldstein JC, Fitzgerald P, Green DR: p53 induces apoptosis by caspase activation through mitochondrial cytochrome c release. J Biol Chem 275:7337-7342, 2000
23. Ding HF, McGill G, Rowan S, Schmaltz C, Shimamura A, Fisher DE: Oncogene-dependent regulation of caspase activation by p53 protein in a cell-free system. J Biol Chem 273:28378-28383, 1998
24. Gottlieb E, Oren M: p53 Facilitates pRb cleavage in IL-3-deprived cells: Novel pro-apoptotic activity of p53. EMBO J 17:3587-3596, 1998
25. Marchenko ND, Zaika A, Moll UM: Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling. J Biol Chem 275:16202-16212, 2000
26. Sansome C, Zaika A, Marchenko ND, Moll UM: Hypoxia death stimulus induces translocation of p53 protein to mitochondria. Detection by immunofluorescence on whole cells. FEBS Lett 488:110-115, 2001
27. Mihara M, Erster S, Zaika A, Petrenko O, Chittenden T, Pancoska P, Moll UM: p53 has a direct apoptogenic role at the mitochondria. Mol Cell 11:577-590, 2003
28. Jiang M, Milner J: Bcl-2 constitutively suppresses p53-dependent apoptosis in colorectal cancer cells. Genes Dev 17:832-837, 2003
29. Dumont P, Leu JI, Della Pietra AC, 3rd, George DL, Murphy M: The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 33:357-365, 2003
30. Pochampally R, Li C, Lu W, Chen L, Luftig R, Lin J, Chen J: Temperature-sensitive mutants of p53 homologs. Biochem Biophys Res Commun 279:1001-1010, 2000
31. Crawford L: The 53,000-dalton cellular protein and its role in transformation. Int Rev Exp Pathol 25:1-50, 1983
32. Vogelstein B, Lane D, Levine AJ: Surfing the p53 network. Nature 408:307-310, 2000
33. Freeman DJ, Li AG, Wei G, Li HH, Kertesz N, Lesche R, Whale AD, Martinez-Diaz H, Rozengurt N, Cardiff RD, Liu X, Wu H: PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms. Cancer Cell 3:117-130, 2003
34. Nikolaev AY, Li M, Puskas N, Qin J, Gu W: Parc: A cytoplasmic anchor for p53. Cell 112:29-40, 2003
35. Leng RP, Lin Y, Ma W, Wu H, Lemmers B, Chung S, Parant JM, Lozano G, Hakem R, Benchimol S: Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation. Cell 112:779-791, 2003